Ptc Therapeutics Stock Price Prediction
PTCT Stock | USD 29.09 0.35 1.19% |
Oversold Vs Overbought
49
Oversold | Overbought |
PTC Therapeutics stock price prediction is an act of determining the future value of PTC Therapeutics shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of PTC Therapeutics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of PTC Therapeutics and does not consider all of the tangible or intangible factors available from PTC Therapeutics' fundamental data. We analyze noise-free headlines and recent hype associated with PTC Therapeutics, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting PTC Therapeutics' stock price prediction:EPS Estimate Next Quarter (1.44) | EPS Estimate Current Year (5.88) | EPS Estimate Next Year (4.98) | Wall Street Target Price 27.82 | EPS Estimate Current Quarter 0.5 |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of PTC Therapeutics based on different types of headlines from major news networks to social media. The PTC stock price prediction module provides an analysis of price elasticity to changes in media outlook on PTC Therapeutics over a specific investment horizon. Using PTC Therapeutics hype-based prediction, you can estimate the value of PTC Therapeutics from the perspective of PTC Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards PTC Therapeutics using PTC Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards PTC using crowd psychology based on the activity and movement of PTC Therapeutics' stock price.
PTC Therapeutics Short Interest
A significant increase or decrease in PTC Therapeutics' short interest from the previous month could be a good indicator of investor sentiment towards PTC. Short interest can provide insight into the potential direction of PTC Therapeutics stock and how bullish or bearish investors feel about the market overall. An investor who is long PTC Therapeutics may also wish to track short interest. As short interest increases, investors should be becoming more worried about PTC Therapeutics and may potentially protect profits, hedge PTC Therapeutics with its derivative instruments, or be ready for some potential downside.
200 Day MA 30.1956 | Short Percent 0.1915 | Short Ratio 11.28 | Shares Short Prior Month 11.4 M | 50 Day MA 27.9404 |
PTC Therapeutics Hype to Price Pattern
Investor biases related to PTC Therapeutics' public news can be used to forecast risks associated with an investment in PTC. The trend in average sentiment can be used to explain how an investor holding PTC can time the market purely based on public headlines and social activities around PTC Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of PTC Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about PTC Therapeutics.
PTC Therapeutics Implied Volatility | 0.0 |
PTC Therapeutics' implied volatility exposes the market's sentiment of PTC Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if PTC Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that PTC Therapeutics stock will not fluctuate a lot when PTC Therapeutics' options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in PTC Therapeutics. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in PTC Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying PTC because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
PTC Therapeutics after-hype prediction price | USD 29.09 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current PTC contract
Based on the Rule 16, the options market is currently suggesting that PTC Therapeutics will have an average daily up or down price movement of about 0.0% per day over the life of the 2024-04-19 option contract. With PTC Therapeutics trading at USD 29.09, that is roughly USD 0.0 . If you think that the market is fully incorporating PTC Therapeutics' daily price movement you should consider acquiring PTC Therapeutics options at the current volatility level of 0.0%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
PTC |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of PTC Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
PTC Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of PTC Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in PTC Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of PTC Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
Expected price to next headline |
PTC Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting PTC Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on PTC Therapeutics' historical news coverage. PTC Therapeutics' after-hype downside and upside margins for the prediction period are 25.54 and 32.64, respectively. We have considered PTC Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
PTC Therapeutics is not too volatile at this time. Analysis and calculation of next after-hype price of PTC Therapeutics is based on 3 months time horizon.
PTC Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as PTC Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading PTC Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with PTC Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.12 | 3.57 | 0.11 | 0.03 | 8 Events / Month | 3 Events / Month | In about 8 days |
Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
29.09 | 29.09 | 0.00 |
|
PTC Therapeutics Hype Timeline
PTC Therapeutics is at this time traded for 29.09. The entity has historical hype elasticity of -0.11, and average elasticity to hype of competition of 0.03. PTC is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at 0.12%. %. The volatility of related hype on PTC Therapeutics is about 1310.09%, with the expected price after the next announcement by competition of 29.12. About 97.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 0.81. PTC Therapeutics recorded a loss per share of 8.37. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 8 days. Check out PTC Therapeutics Basic Forecasting Models to cross-verify your projections.PTC Therapeutics Related Hype Analysis
Having access to credible news sources related to PTC Therapeutics' direct competition is more important than ever and may enhance your ability to predict PTC Therapeutics' future price movements. Getting to know how PTC Therapeutics rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how PTC Therapeutics may potentially react to the hype associated with one of its peers.
HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
MBIO | Mustang Bio | (0.04) | 5 per month | 0.00 | (0.07) | 7.35 | (8.49) | 20.58 | |
MDWD | Mediwound | 0.92 | 8 per month | 2.20 | 0.13 | 7.08 | (4.46) | 19.30 | |
YS | YS Biopharma Co | (0.04) | 7 per month | 4.94 | 0.07 | 8.82 | (10.20) | 43.72 | |
MEIP | MEI Pharma | 0.25 | 9 per month | 0.00 | (0.22) | 5.26 | (6.13) | 15.17 |
PTC Therapeutics Additional Predictive Modules
Most predictive techniques to examine PTC price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for PTC using various technical indicators. When you analyze PTC charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
About PTC Therapeutics Predictive Indicators
The successful prediction of PTC Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as PTC Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of PTC Therapeutics based on analysis of PTC Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to PTC Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to PTC Therapeutics's related companies. 2021 | 2022 | 2023 | 2024 (projected) | Days Of Sales Outstanding | 74.85 | 81.28 | 62.67 | 51.74 | Days Of Inventory Outstanding | 179.02 | 178.16 | 38.74 | 36.8 |
Story Coverage note for PTC Therapeutics
The number of cover stories for PTC Therapeutics depends on current market conditions and PTC Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that PTC Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about PTC Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
PTC Therapeutics Short Properties
PTC Therapeutics' future price predictability will typically decrease when PTC Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of PTC Therapeutics often depends not only on the future outlook of the potential PTC Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. PTC Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 74.8 M | |
Cash And Short Term Investments | 876.7 M |
Check out PTC Therapeutics Basic Forecasting Models to cross-verify your projections. For more information on how to buy PTC Stock please use our How to Invest in PTC Therapeutics guide.Note that the PTC Therapeutics information on this page should be used as a complementary analysis to other PTC Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Complementary Tools for PTC Stock analysis
When running PTC Therapeutics' price analysis, check to measure PTC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PTC Therapeutics is operating at the current time. Most of PTC Therapeutics' value examination focuses on studying past and present price action to predict the probability of PTC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PTC Therapeutics' price. Additionally, you may evaluate how the addition of PTC Therapeutics to your portfolios can decrease your overall portfolio volatility.
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
Is PTC Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PTC Therapeutics. If investors know PTC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PTC Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (8.37) | Revenue Per Share 12.531 | Quarterly Revenue Growth 0.834 | Return On Assets (0.12) | Return On Equity (77.40) |
The market value of PTC Therapeutics is measured differently than its book value, which is the value of PTC that is recorded on the company's balance sheet. Investors also form their own opinion of PTC Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is PTC Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PTC Therapeutics' market value can be influenced by many factors that don't directly affect PTC Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PTC Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if PTC Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PTC Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.